Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma
Authors:
- M. Victoria CalvoMCM. Victoria Calvo
- Ana Martín-SuárezAMAna Martín-Suárez
- Alfonso Domínguez-GilADAlfonso Domínguez-Gil
- 28 February 2011
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 44 (2-3) , 260-263
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Mycophenolate Blood Level Monitoring: Recent ProgressAmerican Journal of Transplantation, 2009
- Simple reversed-phase liquid chromatographic assay for simultaneous quantification of free mycophenolic acid and its glucuronide metabolite in human plasmaJournal of Chromatography B, 2007
- Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantationClinical Pharmacology & Therapeutics, 2005
- Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detectionJournal of Chromatography B, 2005
- Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detectionJournal of Chromatography B, 2004
- Validation of a Rapid and Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Free and Total Mycophenolic AcidClinical Chemistry, 2004
- Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring StrategiesAmerican Journal of Transplantation, 2003
- Evaluation of the EMIT Mycophenolic Acid Assay From Dade BehringTherapeutic Drug Monitoring, 1999